23 ms·
What a shame for this to happen so late in the game. I don't know enough about medicine or medical engineering to know if Theranos' core goal is reasonably atta
by danso 11y ago
What a shame for this to happen so late in the game. I don't know enough about medicine or medical engineering to know if Theranos' core goal is reasonably attainable...but having medical practitioners experienced in research and regulations would seem to have almost certainly prevented the shitshow that Theranos now has to dig itself out of...and their knowledge and experience of how much you can or can't fuck with regulators is probably something that Henry Kissinger, despite all of his authority and fame, does not have as much practical guidance on.
- WalterSear 11y agoIt's not even their actual board. This is more shenaniganry. It's all they know.
- cpeterso 11y agoAnd how many medical and lab experts were on Theranos's scientific and medical advisory board before they added these eight? The following press release only mentions two other members (one of whom is the CEO). It also uses the future tense to say "Theranos’ Scientific and Medical Advisory Board will meet quarterly." http://www.businesswire.com/news/home/20160407006056/en/Theranos-Announces-Leading-Medical-Laboratory-Experts-Join http://www.businesswire.com/news/home/20160407006056/en/Ther...
- nxzero 11y agoPretty sure before this there was no scientific and medical advisory board, otherwise, why would they be adding so many members to it at once; meaning if that's the case, seems really, really fishy.
- WalterSear 11y agoThis company is already Andrea Rossi sketchy. Is is appropriate to flag stories about Theranos? I doesn't seem appropriate to let them have an unfettered voice.
- nxzero 11y agoHow is this giving Theranos a "unfettered voice" - seems like the opposite given that there's no one from the company to my knowledge in this thread of comments; yes, I realize the post is a direct link to an article on them.
- WalterSear 11y agoIt's a link to an article that has a very misleading headline. It's the kind of 'accident' I've come to expect from Theranos and Theranos's PR.
- disposeofnick9 11y agoHorse / barn scenario... hard to see how that brand can recover without massive hustle and undeniable demonstration of proof for changed ways.
- pcrh 11y agoTheranos' goals were always fishy. The fact of the matter is that their vaunted "one drop of blood" technology is a smokescreen, as in reality almost all clinical blood tests use a very small amount of material for the actual test (a few micro-litres). The reason why larger quantities of blood are routinely collected pertains not to the quantity used in the actual biochemical assay, but to the number of tests that may be carried out, and the greater ease of handling slightly larger quantities of sample than Theranos aims (aimed?) to handle. That is for their scientific model. Their business model was based mostly on enabling blood to collected without the need for a qualified person (e.g. a phlebotomist or nurse). This they could do because the amount of blood collected, and the method of collection, circumvented existing legislation. However, if it turns out that this method of collection doesn't "scale" then it too is a wash. Their saving grace might be if they can show that they can indeed perform assays on non-professionally collected blood to FDA-level standards. But that remains to be shown.